Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Eur J Neurosci. 2015 May 12;42(2):1830–1838. doi: 10.1111/ejn.12918

Figure 1.

Figure 1

(A) Mean±SE of phase delays produced by 4 hourly injections of muscimol (21.9mM) into the SCN region between CT13.5 and CT16.5 (hit = animals receiving injections of muscimol within 500µm of the SCN; miss = animals receiving injections of muscimol more than 500µm from the SCN; *, p=0.021, vs. vehicle controls). (B) Mean±SE of phase delays produced by 4 hourly injections of muscimol (doses ranged from 6.6mM to 35.1mM) into the SCN region between CT13.5 and CT16.5. The magnitude of phase delays was dose-dependent (p=0.001). (C, D) Representative activity records demonstrating the effect of 4 hourly injections of vehicle (C) or muscimol (21.9mM) (D) into the SCN region between CT13.5 and CT16.5 on wheel running rhythms in DD. Bars depict the 4-hour injection period (white: saline; shaded: muscimol).